Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ironwood Pharmaceuticals (IRWD) Receivables - Other (2016 - 2020)

Ironwood Pharmaceuticals' Receivables - Other history spans 11 years, with the latest figure at $73.4 million for Q1 2020.

  • For Q1 2020, Receivables - Other rose 5.88% year-over-year to $73.4 million; the TTM value through Mar 2020 reached $73.4 million, up 5.88%, while the annual FY2019 figure was $106.0 million, 76.73% up from the prior year.
  • Receivables - Other for Q1 2020 was $73.4 million at Ironwood Pharmaceuticals, down from $106.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $106.0 million in Q4 2019 and bottomed at $50.0 million in Q1 2017.
  • The 5-year median for Receivables - Other is $65.7 million (2018), against an average of $68.3 million.
  • The largest annual shift saw Receivables - Other soared 99.58% in 2016 before it decreased 27.2% in 2018.
  • A 5-year view of Receivables - Other shows it stood at $63.9 million in 2016, then rose by 23.54% to $79.0 million in 2017, then fell by 24.07% to $60.0 million in 2018, then soared by 76.73% to $106.0 million in 2019, then crashed by 30.73% to $73.4 million in 2020.
  • Per Business Quant, the three most recent readings for IRWD's Receivables - Other are $73.4 million (Q1 2020), $106.0 million (Q4 2019), and $94.6 million (Q3 2019).